Davenport & Co LLC
- SEC CIK
- 0000887777
- Latest filing
- Jul 13, 2026
REGN holding history
Regeneron Pharmaceuticals, Inc. in every 13F filed by Davenport & Co LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
REGN overviewAll 13F holders of REGNFull Q2 2026 holdings
- Shares (Q2 2026)
- 543
- Value
- $338.6K
- % of portfolio
- <0.1%
- Quarters held
- 19
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 543 | $338.6K | <0.1% | +55+11.3% | Added | Holders |
| Q1 2026 | 488 | $377.0K | <0.1% | +123+33.7% | Added | Holders |
| Q4 2025 | 365 | $281.7K | <0.1% | +365 | New | Holders |
| Q3 2025 | 0 | $0 | 0.0% | −394−100.0% | Sold out | Holders |
| Q2 2025 | 394 | $206.9K | <0.1% | −33−7.7% | Reduced | Holders |
| Q1 2025 | 427 | $270.9K | <0.1% | +427 | New | Holders |
| Q4 2024 | 0 | $0 | 0.0% | −430−100.0% | Sold out | Holders |
| Q3 2024 | 430 | $452.0K | <0.1% | +60+16.2% | Added | Holders |
| Q2 2024 | 370 | $388.9K | <0.1% | −82−18.1% | Reduced | Holders |
| Q1 2024 | 452 | $435.0K | <0.1% | +78+20.9% | Added | Holders |
| Q4 2023 | 374 | $328.5K | <0.1% | −3−0.8% | Reduced | Holders |
| Q3 2023 | 377 | $310.3K | <0.1% | −2,601−87.3% | Reduced | Holders |
| Q2 2023 | 2,978 | $2.14M | <0.1% | −939−24.0% | Reduced | Holders |
| Q1 2023 | 3,917 | $3.22M | <0.1% | −1,015−20.6% | Reduced | Holders |
| Q4 2022 | 4,932 | $3.56M | <0.1% | −90−1.8% | Reduced | Holders |
| Q3 2022 | 5,022 | $3.46M | <0.1% | −49−1.0% | Reduced | Holders |
| Q2 2022 | 5,071 | $3.00M | <0.1% | +28+0.6% | Added | Holders |
| Q1 2022 | 5,043 | $3.52M | <0.1% | +243+5.1% | Added | Holders |
| Q4 2021 | 4,800 | $3.03M | <0.1% | +2,121+79.2% | Added | Holders |
| Q3 2021 | 2,679 | $1.62M | <0.1% | +2,141+398.0% | Added | Holders |
| Q2 2021 | 538 | $300.0K | <0.1% | +538 | New | Holders |